PharmaShots Weekly Snapshots (May 31 - June 4, 2021)
Published: June 4, 2021 | Tags: Tonix Pharmaceuticals, TNX-102 SL, P-III, RELIEF Study, Fibromyalgia, ASCP 2021
Dermavant Submits NDA to the US FDA for Tapinarof Cream to Treat Plaque Psoriasis
Published: June 4, 2021 | Tags: Dermavant, NDA, US, FDA, Tapinarof Cream, Plaque Psoriasis
Published: June 4, 2021 | Tags: BMS, Opdivo, nivolumab, CT, Yervoy, ipilimumab, P-III, CheckMate -648 Trial, Unresectable, Advanced, Metastatic, ESCC, ASCO 2021
Published: June 4, 2021 | Tags: United Therapeutics, P-III, TETON Study, Tyvaso, Idiopathic Pulmonary Fibrosis
Published: June 4, 2021 | Tags: Merck, Keytruda, pembrolizumab, P-III, KEYNOTE-564, Renal Cell Carcinoma, ASC0 2021
Published: June 4, 2021 | Tags: Innovent, Lilly, Tyvyt, sintilimab injection, Gemcitabine, Platinum CT, NMPA, Approval, Squamous Non-Small Cell Lung Cancer
Published: June 3, 2021 | Tags: Biogen, Bio-Thera, BAT1806, biosimilar, tocilizumab, P-III, Study, Rheumatoid Arthritis
Lupin Reports the US FDA Acceptance of BLA for Pegfilgrastim Biosimilar
Published: June 3, 2021 | Tags: Lupin, US, FDA, Acceptance, BLA, Pegfilgrastim Biosimilar
Published: June 3, 2021 | Tags: Celltrion, Yuflyma, biosimilar, adalimumab, P-III, CT-P17 3.1 Trial, Rheumatoid Arthritis, EULAR 2021
Published: June 3, 2021 | Tags: Novartis, Kymriah, P-II, ELARA Study, Follicular Lymphoma, ASCO 2021
Published: June 3, 2021 | Tags: BMS, Opdivo, nivolumab, Yervoy, ipilimumab, EC, Approval, Unresectable, Malignant Pleural Mesothelioma
MorphoSys to Acquire Constellation Pharmaceuticals for ~$1.7B
Published: June 3, 2021 | Tags: MorphoSys, Acquire, Constellation Pharmaceuticals, ~$1.7B
Published: June 2, 2021 | Tags: AbbVie, Rinvoq, upadacitinib, P-III, SELECT-COMPARE Study, Rheumatoid Arthritis, EULAR 2021
Novartis Presents Two-Year Data of Cosentyx in P-III JUNIPERA Study for JPsA and ERA at EULAR 2021
Published: June 2, 2021 | Tags: Novartis, Cosentyx, P-III, JUNIPERA Study, JPsA, ERA, EULAR 2021
Published: June 2, 2021 | Tags: AstraZeneca, Anifrolumab, P-III, TULIP Study, Systemic Lupus Erythematosus, EULAR 2021
Published: June 2, 2021 | Tags: Alnylam, P-III, APOLLO-B Study, Patisiran, Transthyretin-Mediated (ATTR) Amyloidosis, Cardiomyopathy
Published: June 2, 2021 | Tags: Janssen, Teclistamab, US, FDA, Breakthrough Therapy Designation, Multiple Myeloma
Published: June 2, 2021 | Tags: Novartis, Cosentyx, secukinumab, US, FDA, Approval, Moderate, Severe, Plaque Psoriasis
Published: June 1, 2021 | Tags: Santhera, ReveraGen, Vamorolone, P-IIb, VISION-DMD Study, Duchenne Muscular Dystrophy
Amgen and Kyowa Kirin Collaborate to Develop and Commercialize KHK4083 for Atopic Dermatitis
Published: June 1, 2021 | Tags: Amgen, Kyowa Kirin, Develop, Commercialize, KHK4083, Atopic Dermatitis
Biohaven's Nurtec ODT (rimegepant) Receives the US FDAs Approval for Treatment of Migraine
Published: June 1, 2021 | Tags: Biohaven, Nurtec ODT, Rimegepant, US, FDA, Approval, Migraine
AB Science Holds the Clinical Studies of Masitinib Globally
Published: June 1, 2021 | Tags: AB Science, Holds, Clinical Studies, Masitinib
Published: June 1, 2021 | Tags: Sanofi, P-II/III, STAGED-PKD Study, Venglustat, Autosomal Dominant Polycystic Kidney Disease
Published: June 1, 2021 | Tags: BMS, Abecma, idecabtagene vicleucel, Health Canada, Approval, Anti-BCMA, CAR T Cell Therapy, Multiple Myeloma
Published: May 31, 2021 | Tags: Ipsen, US, FDA, NDA, Palovarotene, Fibrodysplasia Ossificans Progressiva
Novo Nordisk Resubmits Label Expansion Application to the US FDA for Semaglutide (2.0mg)
Published: May 31, 2021 | Tags: Novo Nordisk, Resubmits, Label Expansion Application, US, FDA, Semaglutide (2.0mg)
Published: May 31, 2021 | Tags: BridgeBio, Helsinn, Truseltiq, infigratinib, US, FDA, Approval, Cholangiocarcinoma
Published: May 31, 2021 | Tags: Novartis, Beovu, brolucizumabin, P- III, MERLIN Study, Wet Age-Related Macular Degeneration
Published: May 31, 2021 | Tags: Pfizer, BioNTech, EC, Conditional Marketing Approval, COVID-19 Vaccine
Published: May 31, 2021 | Tags: Amgen, Lumakras, sotorasib, US, FDA, Approval, KRAS Blocking Cancer Therapy
Related Post: PharmaShots Weekly Snapshots (May 24 - 28, 2021)
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com